ACC slides: Cardiac troponin can measure risk in ischemic heart disease

Editorial Staff | | Cardiovascular Business | Structural Heart Disease

SAN FRANCISCO—Serial measurements of cardiac troponin using an investigational high-sensitivity assay enhanced risk stratification for cardiovascular disease and heart failure in patients with stable ischemic heart disease, according to an analysis of the PROVE IT-TIMI 22 study, presented March 9 at the American College of Cardiology’s (ACC) scientific session.

Cardiac troponin is an emerging prognostic biomarker in patients with stable ischemic heart disease. In this study, lead investigator Ryan G. O'Malley, MD, of Brigham and Women's Hospital in Boston, and colleagues assessed the prognostic performance of serial measurements of an investigational high-sensitivity cardiac troponin assay in patients with stable ischemic heart disease.

ACC slides: Cardiac troponin can measure risk in ischemic heart disease from trimedmedia

 

About the lead author:

Dr. O'Malley is in the internal medicine/adult primary care department of Brigham and Women's Hospital in Boston.

Editorial Staff

Related Content

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement
Hydra TAVR valve gains key approval as global reach continues to grow
SAVR outperforms TAVR in patients with bicuspid aortic valves
Treating AFib patients with TAVR still linked to elevated risks
Heart surgeons detail world’s first robotic heart procedure of its kind
Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.